A novel immunogen to modulate cytokine production and promote immune system reconstitution in HIV-AIDS

American Journal of Therapeutics

Volumn 19, Issue 5, 2012, Pages 317-323

  Segal, Jack L ^a   Thompson, John F ^b   Charter, Richard A ^c  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

Author keywords

AIDS; CD4+; cytokines; HIV; immune; Kveim antigen; peripheral mononuclear blood cells; reconstitution

Indexed keywords

ANTIGEN; ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; PHYTOHEMAGGLUTININ; THYMIDINE; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AIDS PATIENT; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; EX VIVO STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SARCOIDOSIS; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CELL PROLIFERATION; CYTOKINES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; KVEIM TEST; LEUKOCYTES, MONONUCLEAR; LINEAR MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84866360726     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3182204fd9     Document Type: Article

References (15)

1. Bernstein A. Editorial: AIDS and the next 25 years. Science. 2008;320:717.
2. Jasny B, Mueller K, Roberts L. HIV/AIDS: Eastern Europe. Introduction. Science. 2010;329:159.
3. Feldt LS, Charter RA. Estimates of internal consistency reliability when test parts vary in effective length. Meas Eval Couns Dev. 2003;36:23-27.
4. Cohen J. Confronting the limits of success. News focus. Science. 2002;296:2320-2324.
5. Klein SA, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS. 1997;11: 1111-1118.
6. Munro CS, Mitchell DN, Poulter LW, et al. Early cellular responses to intradermal injection of Kveim suspension in normal subjects and those with sarcoidosis. J Clin Pathol. 1986;39:176-182.
7. Chase MW. The preparation and standardization of Kveim testing antigen. Am Rev Resp Dis. 1961;84:86-88.
8. James DG. Sarcoidosis. In: Wyngaarden JB, Smith LH Jr, eds. Cecil Textbook of Medicine. 17th ed. Philadelphia, PA: WB Saunders; 1985:432-439.
9. Newman TG, Minkowitz S, Hanna A, et al. Coexistent sarcoidosis and HIV infection. Chest. 1992;102:1899-1901.
10. Gowda KS, Mayers I, Shafran SD. Concomitant sarcoidosis and HIV infection. Can Med Assoc J. 1990;142:136-137.
11. Lowery WS, Whitlock WL, Dietrich RA, et al. Sarcoidosis complicated by HIV infection: three case reports and a review of the literature. Am Rev Respir Dis. 1990;142: 887-889.
12. Granieri J, Wisnieski JJ, Graham RC, et al. Sarcoid myopathy in a patient with human immunodeficiency virus infection. South Med J. 1995;88:591-595.
13. Foulon G, Wislez M, Naccache JM, et al. Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy. Clin Infect. 2004;38:418-425.
14. Barnes PJ. Cytokine modulators as novel therapies for asthma. Ann Rev Pharmacol Toxicol. 2002;42:81-98.
15. Isogai S, Athiviraham A, Fraser RS, et al. Interferongamma-dependent inhibition of late allergic responses and eosinophilia by CD8+ gammadelta T Cells. Immunology. 2007;122:230-238.